Capricor Therapeutics Inc - Asset Resilience Ratio

Latest as of March 2026: 53.08%

Capricor Therapeutics Inc (CAPR) has an Asset Resilience Ratio of 53.08% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$173.19 Million

Cash + Short-term Investments

Total Assets

$326.28 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Capricor Therapeutics Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Capricor Therapeutics Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Capricor Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Capricor Therapeutics Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$173.19 Million	53.08%
Total Liquid Assets	$173.19 Million	53.08%

Asset Resilience Insights

Very High Liquidity: Capricor Therapeutics Inc maintains exceptional liquid asset reserves at 53.08% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Capricor Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Capricor Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for Capricor Therapeutics Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Capricor Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	8.51%	$30.28 Million	$355.95 Million	-73.75pp
2024-12-31	82.25%	$140.23 Million	$170.48 Million	+40.04pp
2023-12-31	42.21%	$24.79 Million	$58.73 Million	-21.30pp
2022-12-31	63.52%	$31.82 Million	$50.09 Million	--
2021-12-31	0.00%	$0.00	$41.33 Million	--
2020-12-31	0.00%	$0.00	$34.62 Million	--
2019-12-31	53.86%	$5.99 Million	$11.11 Million	+21.45pp
2018-12-31	32.41%	$3.00 Million	$9.25 Million	-16.65pp
2017-12-31	49.07%	$7.98 Million	$16.27 Million	-20.23pp
2016-12-31	69.29%	$12.99 Million	$18.75 Million	+19.52pp
2015-12-31	49.78%	$8.00 Million	$16.07 Million	+27.94pp
2014-12-31	21.84%	$2.98 Million	$13.63 Million	+15.94pp
2013-12-31	5.90%	$326.49K	$5.54 Million	-71.41pp
2012-12-31	77.31%	$4.19 Million	$5.42 Million	--
2011-12-31	0.00%	$0.00	$1.37 Million	--

pp = percentage points

About Capricor Therapeutics Inc

NASDAQ:CAPR USA Biotechnology

Market Cap

$222.96 Million

Market Cap Rank

#16071 Global

#3784 in USA

Share Price

$3.85

Change (1 day)

-8.11%

52-Week Range

$3.85 - $35.34

All Time High

$47.50